NGNE

Conviction 92HealthcareScan · Thu, Jun 25, 2026

Gravestone doji

NGNE$30.40+1.10%

ResistanceSupportVol 14Insider sell

Vol MA14 205.84K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Neurogene Inc.PHARMACEUTICAL PREPARATIONSwww.neurogene.com ↗

Price30.40

Change+1.10%

Gap+1.48%

Rel volume2.30×

Avg volume169.34K

Avg $ vol4.98M

SMA 2028.92

SMA 5028.48

SMA 20023.36

Price vs 50+6.74%

Price vs 200+30.12%

MA stackbullish

50/200 cross—

Supertrendup · 26.22

RSI (14)56

MACD hist0.15

MACD crossbull · 9d

Stoch %K / %D68 / 69

ADX (14)17

+DI / −DI19 / 14

RSI divergence—

MACD divergence—

ATR %+6.46%

ADR %6.72%

52w high34.37

52w low14.95

From 52w high-11.55%

Above 52w low+103.34%

New 52w highNo

SqueezeOff

Bollinger width23.55%

%B0.72

Donchian pos68.16%

Donchian high32.97

Donchian low24.91

AVWAP (52w high)24.24

vs AVWAP high+25.42%

AVWAP (52w low)23.37

vs AVWAP low+30.07%

OBV trendUp

Chaikin MF (20)0.01

Today vs 20d2.30×

Avg vol (14d)205.84K

Avg vol (20d)169.34K

Avg $ vol (20d)4.98M

Market cap480.38M

RS 3m (vs SPY)+31.62%

RS 6m (vs SPY)+38.59%

RS line new highNo

Trend template6/8

Technical rank84.4

1 week-1.27%

1 month+12.18%

3 months+37.99%

6 months+45.80%

1 year+76.74%

YTD+50.79%

P/E-5.32

P/B2.02

P/S—

P/FCF-6.13

EPS-4.24

Div yield—

ROE-38.00%

ROA-34.34%

Debt/Eq—

Current13.08

EV/EBITDA-3.55

Gross margin—

Net margin—

Rev growth-100.00%

EPS growth-20.24%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value356.22M

Revenue0

Net income-30.93M

Gross profit—

Free cash flow-78.36M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out15.8M

Employees131

ListedTue, Dec 19, 2023

Free float9.74M

Float %62.9%

Short interest3.55M

Days to cover27.5d

Short volume61.4%

Squeeze score94 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$1.39 vs −$1.35

Last surprise-3.0% miss

Setup gradeA+

Conviction92 / 100

Pattern quality—

Tech rank84.4 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmGravestone doji

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in NGNE

All disclosures →

No recent disclosed trades by Congress in NGNE. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in NGNE · 1 buy · 1 sell

Insider	Side	Shares	Value	Traded	Filed
Cvijic Christine Mikail President and CFO · Common Stock · 2026-05-06	Sell	4.8K	$156K	2026-05-06	2026-05-08
Shafer Christina Chief Commercial Officer · Non-Qualified Stock Option (right to buy) · 2026-05-05	Grant	120K	$0	2026-05-05	2026-05-07

SEC filings

EDGAR filings in NGNE · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.